Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

In today’s ACT Brief, we examine how large de-identified datasets are reshaping trial design and site strategy, why global ...

As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.

The new approach brings research directly to participants using decentralised and patient-centric digital engagement tools.

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at ...

The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...

This article is part of our series on clinical data considerations. Read How to Prepare for Disclosure. For publicly traded biotech companies, disclosing clinical trial data can be an exciting ...